APFID

Home > ISAAR > Past ISAARs


ISAAR 2011

April 6-8, 2011
COEX, Seoul, Korea

Plenary keynote lectures
Category Date Tentative Title Speaker
Present and future of antimicrobial resistance April 6
10:40-11:20
Evolution of antimicrobial resistance :
what will happen in the bugs ?
David Livermore
April 6
11:20-12:00
Antimicrobial combination therapy in the era of multidrug resistance : how does it work ?
Robert Moellering
Prevention and control of resistance : vaccination กก April 6
16:30-7:10
Developing vaccines for the poor : the IVI experience Cecil Czerkinsky
Major resistant pathogen and its mechanism April 7
10:40-11:20
Methicilin-resistant Staphylococcus aureus :
a comprehensive view
Keiichi Hiramatsu
Prevention and control of resistance : international collaborationกก April 7
11:20-12:00
International initiatives to control antimicrobial resistance :
"I care" project
Jae-Hoon Song

Major resistance issue in the 21st century

April 7
16:30-7:10
XDR & PDR Gram-negative bacilli : an extreme model of resistance Matthew Falagas
Treatment of major infections April 8
10:40-11:20
Treatment of implantable cardiac device infections :
a clinical dilemma in the era of resistance

Walter Wilson
April 8
11:20-12:00
Discovery of novel antibacterial agents : Looking back, Moving forward Karen Bush
DAY 1: Major Resistant Pathogens
Session Tentative Topic Speaker
April 6 (08:30 - 10:30)
Session 1
Streptococcus pneumoniae:
Are we overcoming pneumococcal resistance?
Changing epidemiology of pneumococcal diseases in the post-vaccine era Ron Dagan
In vitro pneumococcal resistance :
what does it mean in the clinical practice ?
Donald Low
Role of Streptococcus pneumoniae in the era of pandemic influenza Keith Klugman
Session 2
MRSA in the hospital and the comunity : The Return of the King
Nosocomial MRSA : the classic threat in the hospital continues Hui Wang
Community-associated MRSA : a clear and present danger Keryn Christiansen
SCCmec : diversity and evolution Teruyo Ito
Treatment options for MRSA infections Robert Moellering
Session 3
ESBLs, AmpCs, & Carbapenemases in Enterobacteriaceae
Global threat of KPC carbapenemase Karen Bush
Emergence of non-KPC carbapenemase : NDM and more David Livermore
Current status of ESBLs and AmpCs : clinical implications & treatment options Po-Ren Hsueh
April 6 (14:20 - 16:20)
Session 4
Major issues of resistance in the Asia Pacific region : an epicenter of resistance
Major resistance problem in China Minggui Wang
Major resistance problem in India V. Ramasubramanian
Major resistance problem in Southeast Asia Visanu Thamlikitkul
Major resistance problem in Far East Asia Shigefumi Maesaki
Session 5
Clinical Microbiology Lab : what's new in the future ?
Antimicrobial susceptibility testing : improved detection of beta-lactam resistance Mary Jane Ferraro
Genetic detection of antimicrobial resistance : an update Franklin Cockerill
Advanced technologies to identify pathogens : what's new? Keryn Chirstiansen
Session 6
MDR, XDR & PDR Gram-negative non-fermenters
MDR in MBLs-producers David Paterson
MDR in OXA carbapenemases-producers Kyungwon Lee
Clinical implication and treatment options for MDR & PDR Acinetobacter Matthew E. Falagas
April 6 (17:10 - 18:00)
Interactive
Session 1
Treatment of infection by MDR Gram-positive infections :
MDR pneumococci, MRSA, VRE infections
Robin Patel
Walter Wilson
Donald Low
DAY 2 : Prevention and Control of Resistance
Session Tentative Topic Speaker
April 7 (08:30 - 10:30)
Session 7
New vaccines on the horizon
Vaccines against enteric infections : cholera, typhoid and shigellosis Nitin Shah
Pneumococcal vaccines : past, present and future Keith Klugman
Rotavirus vaccine Paul Kilgore
Session 8
Antibiotic stewardship : where are we now?
This session is co-organized by ISC and WSPC.
What resistance means to the prescribers Ian Gould
Antimicrobial stewardship in Asian countries Victor Lim
Antimicrobial stewardship in European countries Stephan Harbarth
Antimicrobial stewardship in USA: How to "Get Smart" ? Lauri Hicks
Session 9
Pediatric infections
Childhood pneumonia: a global perspective Nancy Henry
What's new in pediatric enteric infections? Cheng-Hsun Chiu
Otitis media: a contiuning problem in the era of resistance Ron Dagan
Respiratory Virus Infection in High-Risk Children     

Yae-Jean Kim

April 7 (14:20 - 16:20)
Session 10
Experimental vaccines
for the future
This session is co-organized
by IVI.
Vaccines in the 21st century: whats' next? Margaret Liu
Staphylococcal vaccine: where are we now? Douglas Girgenti
The Holy Grail: Universal Vaccines for Influenza? Leo Poon
HIV/AIDS vaccine Margaret Liu
Session 11
PK/PD
The use of beta-lactamase inhibitors to reconquer resistance Johan Mouton
Old drugs, new uses and the pitfalls in between John Turnidge
How can we improve the use of new lipopeptides Vincent Tam
PK/PD of colistin and clinical outcomes of MDR gram negative infections Visanu Thamlikitkul
Session 12
Antimicrobial resistance in animals
Emerging antimicrobial resistant pathogens in animals Yong Ho Park
Risk assessment for antimicrobial use in food animals Tom Shryock
Risk management interventions of resistance in animals H. Scott Hurd
April 7 (17:10 - 18:00)
Interactive
Session 2

Treatment of infection by MDR Gram-negative infections :
PDR Acinetobacter pneumonia, Carbapenemase-producing K. pneumoniae bacteremia

David Paterson
Frank Cockerill
Matthew Falagas
Day 3 (March 20th ) : Prevention and control of antimicrobial resistance
Session  Tentative Topic Speaker
April 8 (08:30 - 10:30)
Session 13
Treatment of invasive fungal infections (interactive session)
Cases of invasive fungal infections :
candidiasis, aspergillosis, cryptococcosis
Thomas Patterson
Boonmee Sathapatayavongs  
David Ellis   
Monica Slavin
Session 14
Emergency preparedness for pandemics, bioterrorism or emerging infections
Lessons from SARS and H1N1 Thomas So
Emering pathogens as a threat for future pandemics Donald Low
Contingency planning: how does healthcare facilities survive? Walter Wilson
Session 15
New antimicrobial agents on the horizon
New antibiotics mainly against resistant Gram-positives Robin Patel
New antibiotics mainly against resistant Gram-negatives David Paterson
New uses of old antibiotics: recycling works! John Turnidge
April 8 (14:20 - 16:20)
Session 16
Treatment of HIV/AIDS  (interactive session)
Case : Immune reconstitution inflammatory syndrome in HIV patients Myoung-Don Oh
Case : Managing adverse reactions to antiretroviral therapy in HIV patients Patrick Chung Ki Li
Case : Antiretroviral therapy for the HIV patients with antiretroviral resistance Koya Ariyoshi  
Session 17
Infection control of resistant pathogens
Infection control of MDR Gram-negaive bacilli : practical approaches Wing Hong Seto
Control of MRSA in the hospital: Is it really possible? Stephan Harbarth
Application of antimicrobial stewardship and infection control program to control PDR-A. baumannii in resource-limited setting Anucha Apisarnthanarak
Session 18
Treament of MDR & XDR tuberculosis
Global epidemiology of MDR & XDR tuberculosis Chen-Yuan Chiang
Mechanism of drug resistance in M. tuberculosis Ying Zhang
Treatment of MDR & XDR tuberculosis Wing Wai Yew
 
์ต์Šคํ”Œ๋กœ๋Ÿฌ,์‚ฌํŒŒ๋ฆฌ,ํฌ๋กฌ,ํŒŒ์ด์–ดํญ์Šค,์˜คํŽ˜๋ผ์—์„œ ์ž‘๋™ํ•จ